Researchers begin study of Ebola vaccine in Africa

The first study of a possible Ebola vaccine is underway in Africa: University of Maryland researchers say three health care workers in Mali received the experimental shots.

The U.S. government developed the vaccine. First-stage human safety testing began last month in the U.S. and Britain. University of Maryland researchers announced the Mali study Thursday as part of that broader safety testing and aim to enroll 40 health workers there.

The Ebola outbreak is in Liberia, Sierra Leone and Guinea. Mali hasn't had any cases but borders Guinea, and health authorities there are on guard.

Researchers say early safety tests should be done in Ebola-free countries to avoid complicating factors. If the vaccine appears safe, larger trials could be carried out in the outbreak zone early next year.

© 2014 The Associated Press. All rights reserved.

Citation: Researchers begin study of Ebola vaccine in Africa (2014, October 9) retrieved 19 March 2024 from https://medicalxpress.com/news/2014-10-ebola-vaccine-africa.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Ebola vaccine trials being fast-tracked: researchers (Update)

 shares

Feedback to editors